A study of chimeras constructed with the two domains of angiotensin I-converting enzyme

Biochemical Pharmacology

Volumn 51, Issue 1, 1996, Pages 11-14

  Williams, Tracy A ^a   Danilov, Sergeï ^a   Alhenc Gelas, François ^a   Soubrier, Florent ^a  

^a INSERM   (France)

Author keywords

chimeras; monoclonal antibody

Indexed keywords

CHIMERIC PROTEIN; COMPLEMENTARY DNA; DIPEPTIDYL CARBOXYPEPTIDASE; MONOCLONAL ANTIBODY;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SUBSTRATE; ENZYME SYNTHESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; SITE DIRECTED MUTAGENESIS;

EID: 0030029914     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(95)02125-6     Document Type: Article

References (15)

1. Ehlers MRW and Riordan JF, Angiotensin-converting enzyme: New concepts concerning its biological role. Biochemistry 28: 5311-5318, 1989.
2. Soubrier F, Alhenc-Gelas F, Hubert C, Allegrini J, John M, Tregear G and Corvol P, Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning. Proc Natl Acad Sci USA 85: 9386-9390, 1988.
3. Wei L, Alhenc-Gelas F, Corvol P and Clauser E, The two homologous domains of the human angiotensin I-converting enzyme are both catalytically active. J Biol Chem 266: 9002-9008, 1991.
4. Ehlers MRW and Riordan J, Angiotensin-converting enzyme: Zinc- and inhibitor binding stoichiometries of the somatic and testis isozymes. Biochemistry 30: 7118-7126, 1991.
5. Williams TA, Barnes K, Kenny AJ, Turner AJ and Hooper NM, A comparison of the zinc content and substrate specificity of the endothelial and testicular forms of porcine angiotensin converting enzyme, and the isolation of isoenzyme specific antisera. Biochem J 288: 878-881, 1992.
6. Wei L, Clauser E, Alhenc-Gelas F and Corvol P, The two homologous domains of human angiotensin I-converting enzyme interact differently with competitive inhibitors. J Biol Chem 267: 13398-13405, 1992.
7. Jaspard E, Wei L and Alhenc-Gelas F, Differences in properties and enzymatic specificities between the two active sites of angiotensin I-converting enzyme. Studies with bradykinin and other natural peptides. J Biol Chem 268: 9496-9503, 1993.
8. Perich RB, Jackson B, Rogerson F, Mendelsohn FAO, Paxton D and Johnston CI, Two binding sites on angiotensin-converting enzyme: Evidence from radioligand binding studies. Mol Pharmacol 42: 286-293, 1992.
9. Danilov S, Jaspard E, Churakova T, Towbin H, Savoie F, Wei L and Alhenc-Gelas F, Structure-function analysis of angiotensin I-converting enzyme using monoclonal antibodies. J Biol Chem 269: 26806-26814, 1994.
10. Wei L, Alhenc-Gelas F, Soubrier F, Michaud A, Corvol P and Clauser E, Expression and characterization of recombinant human angiotensin I-converting enzyme. Evidence for a C-terminal transmembrane anchor and for a proteolytic processing of the secreted recombinant and plasma enzymes. J Biol Chem 266: 5540-5546, 1991.
11. Kunkel TA, Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc Natl Acad Sci USA 82: 488-492, 1985.
12. Williams TA, Corvol P and Soubrier F, Identification of two active site residues in human angiotensin I-converting enzyme. J Biol Chem 269: 29430-29434, 1994.
13. Sambrook J, Fritsch EF and Maniatis T. Molecular cloning: A Laboratory Manual (2nd Ed.). Cold Spring Harbour Laboratory, Cold Spring Harbour, NY, 1989.
14. Friedland J and Silverstein E, A sensitive fluorimetric assay for serum angiotensin-converting enzyme. Am J Clin Pathol 66: 416-424, 1976.
15. Piquilloud Y, Reinharz A and Roth M, Studies on the angiotensin converting enzyme with different substrates. Biochim Biophys Acta 206: 136-142, 1970.